-
DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication
May 20, 2020, 16:39 PM by Michael CroftLA JOLLA, CA - May 20, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the DermTech Pigmented Lesion Assay (the DermTech PLA) is reviewed in the Journal of the American Academy of Dermatology (JAAD) by leading dermatologists at the New York University School of Medicine as one of four novel molecular technologies with the potential to address current gaps in melanoma management through improved diagnostic accuracy and prognosticationFull story -
2bPrecise honored as recipient of the 2020 Microsoft Health Innovation Awards
May 20, 2020, 10:02 AM by Michael CroftPITTSBURGH, PA, UNITED STATES - May 20, 2020 - 2bPrecise Precision Health platform has been named a recipient of Microsoft Corp.s 2020 Health Innovation Awards, in the category of Reimagine HealthcareFull story -
How Data Integration Can Save Lives and Economies During Pandemics
May 20, 2020, 08:20 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Advances in medicine, aided by technology, have saved many lives, no doubt. Credit can be given to many technologies, but when a new kind of viral disease comes along such as COVID-19, we are once again humbled.
-
Sterling Pharma Solutions commence the production of potential COVID-19 treatment
May 18, 2020, 12:58 PM by Michael CroftDUDLEY, UNITED KINGDOM - May 11, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19Full story -
What We’re Discovering About Scientific Computing During A Pandemic
May 18, 2020, 08:50 AM by Michael CroftFull storyBio-IT World | An all-star panel convened for the second half of Bio-IT World’s Trends from the Trenches event earlier this week. Susan K. Gregurick (NIH), Eli Dart (ESnet), Matthew Trunnell (Data Commoner-at-Large), Vivien Bonazzi (Deloitte), and Fernanda Foertter (BioTeam) joined Dagdigian and panel moderator Ari Berman (both of BioTeam) from their own living rooms and offices. But that didn’t keep the socially distanced panel from digging into infrastructure, standards, privacy issues and more, all while staying COVID-19 aware.
-
ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management
May 18, 2020, 02:39 AM by Michael CroftMIAMI, FL - May 4, 2020 - MIAMI, FL April 21, 2020 - ArisGlobal, the leading provider of software that automates core drug development functions for over 300 life sciences companies, today announced the release of LifeSphere CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizesFull story -
Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing
May 18, 2020, 02:35 AM by Michael CroftMIAMI, FL, UNITED STATES - May 1, 2020 - MIAMI, FL April 20, 2020 - ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, today announced that two large multi-national pharmaceutical companies have selected the LifeSphere® Intake and Triage solution to bring substantial efficiency gains to adverse event case processing across their global affiliatesFull story -
Bio-IT Industry Continuing To Gain Insight On COVID-19, And Other News
May 15, 2020, 09:55 AM by Michael CroftFull storyBio-IT World | A genome in pangolins could reveal a treatment option for COVID-19. A lack amount MicroRNA may explain why older individuals and those with preexisting medical conditions are vulnerable for contracting the virus. We round up the week’s research and industry news for COVID-19.
-
NVIDIA Announces New GPU Architecture, AI Compute System, Genomics Analysis Record, Smart Hospital Platform, More
May 14, 2020, 09:35 AM by Michael CroftFull storyBio-IT World | NVIDIA moved its Graphics Technology Conference keynote online today. CEO Jensen Huang hosted the company’s first “kitchen keynote” with hardware laid out on the kitchen counter among spatulas and pepper mills. In the life sciences, NVIDIA announced the first DGX A100 installation, a speed record for genomics analysis from NVIDIA Clara Parabricks computational genomics software, the new NVIDIA Clara Guardian healthcare platform, and AI models for COVID-19.
-
The Pistoia Alliance Launches Toolkit to Accelerate Implementation of FAIR Data Principles
May 14, 2020, 07:14 AM by Michael CroftBOSTON, MA - May 14, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today launched a freely accessible toolkit to help companies implement the FAIR (Findable, Accessible, Interoperable, Reusable) guiding principles for data management and stewardshipFull story -
Kyruus to Power Boston Children’s Hospital’s Next Phase of Digital Transformation
May 13, 2020, 10:46 AM by Michael CroftBOSTON, MA, UNITED STATES - May 13, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that Boston Childrens Hospital, the top pediatric hospital in the United States, has engaged the company to enhance access to its world-renowned providers and facilitiesFull story -
Trends From The Socially Distanced Trenches: Storage, Image Analysis, And What’s Coming For Bio-IT
May 13, 2020, 08:20 AM by Michael CroftFull storyBio-IT World | The 10th anniversary of Chris Dagdigian’s Trends from the Trenches presentation kicked off yesterday to hundreds of audience members in attendance—but this time virtually.
-
Engility® CTMS Selected by Leading US Health Outcomes and Technology Company for its Clinical Trial Programmes
May 13, 2020, 08:15 AM by Michael Croft, ENGLAND - May 12, 2020 - PHARMASEAL, a new provider of clinical trial management and governance solutions, announced today that a leading US health outcomes and technology company has selected Engility® Clinical Trial Management system for the management and oversight of its clinical trial programmesFull story -
SEKISUI XenoTech Receives New US Patent for a Method to Evaluate Xenobiotics as Immune-Modulators of Drug Transport and Metabolism in Hepatocytes
May 12, 2020, 08:56 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - May 12, 2020 - SEKISUI XenoTech has been awarded US patent # 10,648,968 In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytesFull story -
Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Tel
May 11, 2020, 17:15 PM by Michael CroftLA JOLLA, CA, US - May 11, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that SKIN, the official journal of the National Society for Cutaneous Medicine, published proof-of-concept data demonstrating that patients are able to reliably perform remote self-sampling of concerning moles using the DermTech Pigmented Lesion Assay (the DermTech PLA) under physician supervision via telemedicine, enabling actionable molecular testing for accurate melanoma detectionFull story -
The Melanoma Research Foundation Hosting Weekly Facebook Live ‘Ask a Dermatologist’ Sessions throughout Melanoma Awareness Month
May 11, 2020, 15:26 PM by Michael CroftLA JOLLA, CA, US - May 5, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech) and the Melanoma Research Foundation (MRF) recognize Melanoma Awareness Month this May with an Ask a Dermatologist webinar series offered on MRFs Facebook page every Thursday throughout the month to raise awareness of melanoma and educate around the dangers of the fastest growing and most deadly form of skin cancerFull story -
Eli Dart On Science DMZs, COVID-19, And The Future Of Computing Infrastructure
May 11, 2020, 15:20 PM by Michael CroftFull storyBio-IT World | TRENDS FROM THE TRENCHES—At the Energy Sciences Network—ESNet—Eli Dart works to help scientists, science collaborations, and facilities more effectively use high performance networking in the conduct of science. He talks with BioTeam's Stan Gloss on the future of networks.
-
DermTech Announces Telemedicine Solution to Enable Remote Use of its Non-Invasive Adhesive Patch Test for Melanoma Detection
May 11, 2020, 15:19 PM by Michael CroftLA JOLLA, CA, US - Apr 30, 2020 - DermTech, Inc. (NASDAQ: DMTK) (DermTech), today announced that its lead non-invasive melanoma detection test, the DermTech Pigmented Lesion Assay (the DermTech PLA), is now available for use by clinicians and their patients via telemedicineFull story -
Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials
May 11, 2020, 10:18 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - May 11, 2020 - As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designsFull story -
Rho Recognized with CRO Leadership Award from Leading Industry Publications
May 11, 2020, 10:12 AM by Michael CroftDURHAM, NC, US - May 11, 2020 - For Immediate ReleaseRho Recognized with CRO Leadership Award fromLeading Industry PublicationsResearch Triangle Park, NC - May 11, 2020 - Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has been honored with a 2020 CRO Leadership Award by leading industry publications Life Science Leader and Clinical Leader for the third timeFull story